Effect of treatment with ethyl pyruvate on multiple organ dysfunction and mortality following delayed resuscitation after burn injury in rat

Chinese Critical Care Medicine

Volumn 18, Issue 3, 2006, Pages 132-135

  Wang, Wen Jiang ^a,b   Yao, Yong Ming ^a   Xian, Li Ming ^a   Dong, Ning ^a   Yu, Yan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Armed Force Police Corps of Beijing   (China)

Author keywords

Burn; Delayed resuscitation; Ethyl pyruvate; Mortality; Multiple organ dysfunction syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; MYELOPEROXIDASE; PYRUVIC ACID ETHYL ESTER; RINGER SOLUTION; SODIUM CHLORIDE; UNCLASSIFIED DRUG; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BURN; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; LUNG PARENCHYMA; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; QUANTITATIVE ANALYSIS; RANDOMIZATION; RAT; RAT STRAIN; RESUSCITATION; SCALD; THICKNESS; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BURNS; DISEASE MODELS, ANIMAL; MALE; MULTIPLE ORGAN FAILURE; PYRUVATES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RESUSCITATION;

EID: 33645648627     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chinese source. 2004,16:321-324.
2. Chinese source. 2004,16:325-327.
3. Fink M P. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution [J]. Curr Opin Clin Nutr Metab Care, 2002,5:167-174.
4. Venkataraman R, Kellum J A, Song M, et al. Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock [J]. Shock, 2002, 18: 507-512.
5. Chinese source. 2005,17:12-15.
6. Fink M P. Ethyl pyruvate: a novel anti-inflammatory agent [J]. Crit Care Med, 2003,31:S51-S56.
7. Song M, Kellum J A, Kaldas H. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264. 7 cells [J]. J Pharmacol Exp Ther, 2004, 308, 307-316.
8. Chinese source. 2005,17:385-387.
9. Fang W H, Yao Y M, Shi Z G, et al. The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury [J]. Shock, 2002,17:329-333.
10. Czura C J, Tracey K J. Targeting high mobility group box 1 as late-acting mediator of inflammation [J]. Crit Care Med, 2003, 31:S46-S49.
11. Chinese source. 2005,17:393-396.
12. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches [J]. Free Radic Biol Med, 2000,28:1405-1420.
13. Chinese source. 2004;29:33-35.
14. Fink M P. Ethyl pyruvate: a novel treatment for sepsis and shock [J]. Minerva Anestesiol, 2004,70:365-371.
15. Woo Y J, Taylor M D, Cohen J E, et al. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia [J]. J Thorac Cardiovasc Surg, 2004, 127: 1262-1269.
16. Yang R, Han X, Delude R L, et al. Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice [J]. J Lab Clin Med, 2003,142:322-331.